Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Anke Morgner"'
Autor:
Marius Bill, Leo Ruhnke, Sven Zukunft, Silvia Schäfer, Jan-Niklas Eckardt, Sebastian Stasik, Maher Hanoun, Thomas Schroeder, Lars Fransecky, Björn Steffen, Stefan W. Krause, Sebastian Scholl, Andreas Hochhaus, Tim Sauer, Sabrina Kraus, Kerstin Schäfer-Eckart, Martin Kaufmann, Edgar Jost, Tim H Brümmendorf, Christoph Schliemann, Jan-Henrik Mikesch, Utz Krug, Mathias Hänel, Anke Morgner, Markus Schaich, Andreas Neubauer, Roland Repp, Dirk Niemann, Ruth Seggewiss-Bernhardt, Achim Meinhardt, Johannes Kullmer, Ulrich Kaiser, Wolfgang Blau, Alexander Kiani, Götz Ulrich Grigoleit, Aristoteles Giagounidis, Alexander Wurm, Heidi Altmann, Jan Moritz Middeke, Johannes Schetelig, Carsten Müller-Tidow, Friedrich Stölzel, Claudia Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser, Christian Thiede, Christoph Röllig
Publikováno v:
HemaSphere, Vol 7, p e72156a7 (2023)
Externí odkaz:
https://doaj.org/article/4f60a7cb94af465e91534560db0cc6e5
Autor:
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena Gaidzik, Michael Lauseker, Oliver Kriege, Mareike Verbeek, Julia Marie Unglaub, Felicitas Thol, Stefan W. Krause, Mathias Hänel, Charlotte Neuerburg, Vladan Vucinic, Christian-Friedrich Jehn, Julia Severmann, Maxi Wass, Lars Fransecky, Jens Chemnitz, Udo Holtick, Kerstin Schäfer-Eckart, Josephine Schröder, Sabrina Kraus, William Krüger, Ulrich Kaiser, Sebastian Scholl, Kathrin Koch, Lea Henning, Guido Kobbe, Rainer Haas, Nael Alakel, Maximilian-Alexander Röhnert, Katja Sockel, Maher Hanoun, Uwe Platzbecker, Tobias A. W. Holderried, Anke Morgner, Michael Heuser, Tim Sauer, Katharina S. Götze, Eva Wagner-Drouet, Konstanze Döhner, Hartmut Döhner, Christoph Schliemann, Johannes Schetelig, Martin Bornhäuser, Ulrich Germing, Thomas Schroeder, Jan Moritz Middeke
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-8 (2021)
Abstract To investigate the efficacy and toxicities of CPX-351 outside a clinical trial, we analyzed 188 patients (median age 65 years, range 26–80) treated for therapy-related acute myeloid leukemia (t-AML, 29%) or AML with myelodysplasia-related
Externí odkaz:
https://doaj.org/article/227f98dd88a74dfd8f202c1342f289b3
Autor:
Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, Stephan Kaun, Anke Morgner, Georg Hess, Thomas Elter, Nikolas von Bubnoff, Martin Dreyling, Mark Ringhoffer, Stefan W. Krause, Günter Derigs, Beate Klimm, D. Niemann, Kristina Fritsch, Jürgen Finke, Gerald Illerhaus
Publikováno v:
Haematologica, Vol 98, Iss 5 (2013)
High-dose chemotherapy followed by autologous stem cell transplantation has been shown to be feasible and highly effective in newly diagnosed primary central nervous system lymphoma. In this retrospective multicenter study, we investigated prognosis
Externí odkaz:
https://doaj.org/article/7c9b5dcb86444f11bffc7618729dc3c3
Autor:
Linus A. Völker, Jessica Kaufeld, Gesa Balduin, Lena Merkel, Lucas Kühne, Dennis A. Eichenauer, Thomas Osterholt, Holger Hägele, Martin Kann, Franziska Grundmann, Benedikt Kolbrink, Kevin Schulte, Anja Gäckler, Andreas Kribben, Kristina Boss, Sebastian A. Potthoff, Lars C. Rump, Tilman Schmidt, Anja S. Mühlfeld, Karsten Schulmann, Matthias Hermann, Jens Gaedeke, Kristin Sauerland, Jörn Bramstedt, Ulrich P. Hinkel, Wolfgang Miesbach, Frederic Bauer, Timm H. Westhoff, Heike Bruck, Veronika Buxhofer-Ausch, Tobias J. Müller, Ralph Wendt, Ana Harth, Adrian Schreiber, Evelyn Seelow, Markus Tölle, Christopher Gohlisch, Markus Bieringer, Gesa Geuther, Wolfram J. Jabs, Michael Fischereder, Anke von Bergwelt-Baildon, Ulf Schönermarck, Paul Knoebl, Jan Menne, Paul T. Brinkkoetter, Fedai Özcan, Silke Markau, Matthias Girndt, Helmut Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Vedat Schwenger, Maximilian Roeder, Jörg Radermacher, Anke Morgner, Regina Herbst, Charis von Auer
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:559-572
BACKGROUND: The von Willebrand factor-directed nanobody caplacizumab has greatly changed the treatment of immune thrombotic thrombocytopenic purpura (iTTP) in recent years. Data from randomized controlled trials established efficacy and safety. OBJEC
Autor:
Nicola Goekbuget, Andreas Viardot, Björn Steffen, Joachim Hahn, Bernd Spriewald, Sonja Martin, Simon Raffel, Lino L. Teichmann, Arne Trummer, Winfried Alsdorf, Anke Morgner, Stefan Schwartz, Matthias Stelljes, Vladan Vucinic, Nael Alakel, Andrea Stoltefuß, Claudia D. Baldus, Monika Brüggemann, Hubert Serve, Dieter Hoelzer
Publikováno v:
Blood. 140:121-123
Autor:
Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, Stefan F. Weber, Johannes Krisam, Lukas Baumann, Jacek Stermann, Uta Merle, Markus A. Weigand, Christian Nusshag, Lars Bullinger, Jens-Florian Schrezenmeier, Martin Bornhäuser, Nael Alakel, Oliver Witzke, Timo Wolf, Maria J. G. T. Vehreschild, Stefan Schmiedel, Marylyn M. Addo, Felix Herth, Michael Kreuter, Phil-Robin Tepasse, Bernd Hertenstein, Mathias Hänel, Anke Morgner, Michael Kiehl, Olaf Hopfer, Mohammad-Amen Wattad, Carl C. Schimanski, Cihan Celik, Thorsten Pohle, Matthias Ruhe, Winfried V. Kern, Anita Schmitt, Hanns-Martin Lorenz, Margarida Souto-Carneiro, Mary Gaeddert, Niels Halama, Stefan Meuer, Hans-Georg Kräusslich, Barbara Müller, Paul Schnitzler, Sylvia Parthé, Ralf Bartenschlager, Martina Gronkowski, Jennifer Klemmer, Michael Schmitt, Peter Dreger, Katharina Kriegsmann, Richard F. Schlenk, Carsten Müller-Tidow
Patients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with high morbidity and mortality. Furthermore, impaired humoral response renders severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines less effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9354f3b1c92e5a06f358a09fb158711e
http://edoc.mdc-berlin.de/23008/2/23008suppl.zip
http://edoc.mdc-berlin.de/23008/2/23008suppl.zip
Autor:
Claudia M Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, Stefan F Weber, Johannes Krisam, Lukas Baumann, Jacek Stermann, Uta Merle, Markus Weigand, Lars Bullinger, Jens-Florian Schrezenmeier, Martin Bornhäuser, Nael Alakel, Oliver Witzke, Timo Wolf, Maria Vehreschild, Stefan Schmiedel, Marylyn Addo, Felix Herth, Michael Kreuter, Phil-Robin Tepasse, Bernd Hertenstein, Mathias Hänel, Anke Morgner, Michael Kiehl, Olaf Hopfer, Mohammad-Amen Wattad, Carl Schimanski, Cihan Celik, Thorsten Pohle, Matthias Ruhe, Winfried Kern, Anita Schmitt, Michael Schmitt, Hanns-Martin Lorenz, Margarida Souto-Carneiro, Niels Halama, Stefan Meurer, Hans-Georg Kräusslich, Barbara Müller, Ralf Bartenschlager, Martina Gronkowski, Jennifer Klemmer, Katharina Kriegsmann, Richard Schlenk, Carsten Müller-Tidow
Publikováno v:
Open Forum Infectious Diseases. 9
Background Patients with hematological malignancy or other cancers as well as immunosuppression bear a high risk for severe COVID-19. Monoclonal antibodies (mAb) are efficient at early stages of the disease but may lose potency with new variants. Tri
Autor:
Katja, Sockel, Friedrich, Stölzel, Franziska, Hönl, Henning, Baldauf, Christoph, Röllig, Martin, Wermke, Malte, von Bonin, Raphael, Teipel, Cornelia, Link-Rachner, Kalina, Brandt, Frank, Kroschinsky, Mathias, Hänel, Anke, Morgner, Christian, Klesse, Gerhard, Ehninger, Uwe, Platzbecker, Martin, Bornhäuser, Johannes, Schetelig, Jan Moritz, Middeke
Publikováno v:
Cancer management and research. 14
Allogeneic hematopoietic cell transplantation (HCT) during chemotherapy-induced aplasia may offer long-term survival in acute myeloid leukemia (AML) with otherwise poor prognosis including ELN adverse risk, relapsed or refractory disease. However, th
Autor:
Martin Bommer, Silke Markau, Wolfram J. Jabs, Charis von Auer, Markus Bieringer, Paul T. Brinkkoetter, Martin Reinhardt, Regina Herbst, Sebastian Brähler, Anja Mühlfeld, Jörg Radermacher, Frederic Bauer, Ralph Wendt, Johanna Schneider, Jan Menne, Hildegard Christ, Alexander Gawlik, Lucas Kühne, Timm H. Westhoff, Saban Elitok, Wolfgang Miesbach, Anja Gäckler, Sebastian A. Potthoff, Jens Gerth, Helmut Felten, M. Tölle, Fedai Özcan, Maximilian Roeder, Jörn Bramstedt, Jessica Kaufeld, Andreas Kribben, Martin Hausberg, Anke Morgner, Jens Gaedeke, Linus A. Völker, Marcus Brand, Stefan Zschiedrich, Adrian Schreiber, Ulf Schoenermarck, Vedat Schwenger, Ana Harth, Matthias Girndt
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare but life-threatening condition. In 2018, the nanobody caplacizumab was approved for the treatment of adults experiencing an acute episode of aTTP, in conjunction with plasma exchange (PEX)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da1d0e9664bad0a2333cb332710f7d7
http://edoc.mdc-berlin.de/19118/1/19118oa.pdf
http://edoc.mdc-berlin.de/19118/1/19118oa.pdf
Autor:
M. Tölle, Wolfram J. Jabs, Fedai Özcan, Lucas Kühne, Jan Menne, Regina Herbst, Timm H. Westhoff, Paul T. Brinkkoetter, Sebastian A. Potthoff, Andreas Kribben, Vedat Schwenger, Alexander Gawlik, Martin Reinhardt, Silke Markau, Ralph Wendt, Anke Morgner, Anja Mühlfeld, Ana Harth, Saban Elitok, Wolfgang Miesbach, Jörg Radermacher, Johanna Schneider, Martin Hausberg, Charis von Auer, Martin Bommer, Markus Bieringer, Maximilian Roeder, Jörn Bramstedt, Frederic Bauer, Helmut Felten, Ulf Schoenermarck, Matthias Girndt, Hildegard Christ, Jessica Kaufeld, Anja Gäckler, Jens Gerth, Jens Gaedeke, Sebastian Brähler, Adrian Schreiber, Linus A. Völker, Marcus Brand, Stefan Zschiedrich
Publikováno v:
Blood Adv
Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925b2ff5793d83294a1ac70f7d152044
http://edoc.mdc-berlin.de/19119/1/19119oa.pdf
http://edoc.mdc-berlin.de/19119/1/19119oa.pdf